Back to company

ABL BIOTEC A/S: Financial statements 2012

CVR: 50811018

ABL BIOTEC A/S (CVR 50811018) has filed annual accounts for 2012. In 2012, the company reported a gross profit of DKK -50,503 and a net result of DKK 3,685,841. Equity amounted to DKK 21,513,448. The solvency ratio was 99.8%.

Gross Profit
-50,503 kr.
Profit/Loss
3,685,841 kr.
Equity
21,513,448 kr.
Total Assets
21,550,630 kr.

Official annual report

View the official annual report directly on the page with a Pro subscription.

How creditworthy is ABL BIOTEC A/S?

See the CDS score and get a full credit report with recommended credit limit and payment terms.

Read about the CDS score

Events in 2012

Auditor steps down at ABL BIOTEC A/SDec 31, 2012

As of December 31, 2012, MJAKP2 I/S has stepped down as auditor of ABL BIOTEC A/S.

About ABL BIOTEC A/S

ABL BIOTEC A/S is a Danish company of the type Aktieselskab based in Højbjerg, founded in 1974. The company is registered under the industry Anden finansiel formidling i.a.n.. The management consists of Asger Bach-Larsen. The company is owned by Asger Bach-Larsen and Kirsten Bach-Larsen. The company has 0 employees. In 2025, the company reported a gross profit of DKK -129,949 and a net result of DKK -116,723 compared with DKK 3,704,421 the year before. Equity amounted to DKK 27,884,586.